Alzheimer's and Dementia

Home Alzheimer's and Dementia Page 2
Alzheimer's clinical trials

Why Latinos Hesitate on Alzheimer’s Clinical Trials

Medical Director Bernardo Ng talks about why Latinos are often hesitant to participate in Alzheimer's clinical trials, beginning with having less access to trial centers, as well as fear of being in a research trial and the fear of being diagnosed with Alzheimer's. Courtesy of Athira Pharma.
Alzheimer's clinical trials

Challenges for Latinos and Alzheimer’s Clinical Trials

Psychiatrist and Medical Director Bernardo Ng of the Sun Valley Research Center joins Suzanne to talk about specific challenges for the Latino community in signing up for Alzheimer's clinical trials, courtesy of Athira Pharma.
Senior couple

Alzheimer’s Clinical Trials and Underserved Minorities

Courtesy of Athira Pharma, Psychiatrist and Medical Director Bernardo Ng of the Sun Valley Research Center joins Suzanne to talk about Alzheimer's clinical trials, particularly in underserved groups such at the Latino populations in the United States.
David Troxel

David Troxel’s Approach to Dementia Care

David Troxel joins Suzanne to talk about his book The Best Friend's Approach to Dementia Care, courtesy of Era Living.
Dr. Michael Mega, Center for Cognitive Health

Get Alzheimer’s Treatments in Clinical Trials

Dr. Michael Mega, director of the Center for Cognitive Health in Portland, OR, talks about the best way to get treatments right now for Alzheimer's is to take part in a clinical trial.
Dr. Michael Mega, Center for Cognitive Health

Advances in Early Detection for Alzheimer’s

Dr. Michael Mega, director of the Center for Cognitive Health in Portland, OR, talks about being able to detect biomarkers for the tau and amyloid plaques that are believed to cause Alzheimer's.
Dr. Michael Mega, Center for Cognitive Health

Avoiding the Paths That Cause Alzheimer’s

Dr. Michael Mega, director of the Center for Cognitive Health in Portland, OR, talks about how diet, lifestyle, cognitive stimulation, and genetics all play into the paths to influence whether we can avoid Alzheimer's.
Kevin Church, Chief Science Officer of Athira Pharma

All About Alzheimer’s Clinical Trials, Part 2

Kevin Church, Chief Science Officer of Athira Pharma, provides an overview of clinical trials, how to find clinical trial locations, and what sorts of things the doctors are looking for in a participant.
Kevin Church, Chief Science Officer of Athira Pharma

All About Alzheimer’s Clinical Trials, Part 1

Kevin Church, Chief Science Officer of Athira Pharma, provides an overview of what happens in a trial, how long they last, and the different kinds of clinical trials.
Kevin Church, Chief Science Officer of Athira Pharma

Reversing Brain Cell Damage from Alzheimer’s

Kevin Church, Chief Science Officer of Athira Pharma, joins Suzanne to talk about what happens to the brain when someone has Alzheimer's, and how Athira's clinical trial aims to reverse damage done to brain cells by Alzheimer's.